Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Terminated 3Completed 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Leiomyoma 4Menorrhagia 2

Interventions

telapristone acetate 13estradiol, norethindrone drug combination 9elagolix 7Estradiol 7relugolix 6Norethindrone Acetate 5vilaprisan 4ulipristal acetate 4Sugars 3Uterine Myomectomy 2Lidocaine 2Leuprolide 2Letrozole 2ulipristal 1epigallocatechin gallate 1Vitamin B 6 1Uterine Artery Embolization 1Tranexamic Acid 1Therapeutics 1Standard of Care 1Sodium Chloride 1Ropivacaine 1Rocuronium 1Progesterone 1Pregabalin 1Morphine 1Misoprostol 1Mifepristone 1Injections, Subcutaneous 1Ibuprofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Leiomyoma × vilaprisan × Clear all
NCT03194646 2025-07-28

ASTEROID 6

Bayer

Phase 3 Terminated
1,272 enrolled 16 charts

Leiomyoma

NCT03400943 2023-05-03

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Bayer

Phase 3 Terminated
93 enrolled 19 charts

Leiomyoma, Menorrhagia

NCT03400956 2022-06-30

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

Bayer

Phase 3 Terminated
103 enrolled 18 charts

Leiomyoma, Menorrhagia

NCT02131662 2017-12-08

ASTEROID 1

Bayer

Phase 2 Completed
309 enrolled 24 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡